These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 30273496)
1. Altered driving performance of symptomatic Huntington's disease gene carriers in simulated road conditions. Jacobs M; Hart EP; Miranda YM; Groeneveld GJ; van Gerven JMA; Roos RAC Traffic Inj Prev; 2018; 19(7):708-714. PubMed ID: 30273496 [TBL] [Abstract][Full Text] [Related]
2. Predictors of simulated driving performance in Huntington's disease. Jacobs M; Hart EP; Mejia Miranda Y; Groeneveld GJ; van Gerven JMA; Roos RAC Parkinsonism Relat Disord; 2019 Mar; 60():64-69. PubMed ID: 30292732 [TBL] [Abstract][Full Text] [Related]
3. Determinants of fitness to drive in Huntington disease. Devos H; Nieuwboer A; Tant M; De Weerdt W; Vandenberghe W Neurology; 2012 Nov; 79(19):1975-82. PubMed ID: 23100397 [TBL] [Abstract][Full Text] [Related]
4. Dissociation between decision-making under risk and decision-making under ambiguity in premanifest and manifest Huntington's disease. Adjeroud N; Besnard J; Verny C; Prundean A; Scherer C; Gohier B; Bonneau D; Massioui NE; Allain P Neuropsychologia; 2017 Aug; 103():87-95. PubMed ID: 28712946 [TBL] [Abstract][Full Text] [Related]
5. Visual Object Perception in Premanifest and Early Manifest Huntington's Disease. Coppen EM; Jacobs M; van der Zwaan KF; Middelkoop HAM; Roos RAC Arch Clin Neuropsychol; 2019 Nov; 34(8):1320-1328. PubMed ID: 30796801 [TBL] [Abstract][Full Text] [Related]
6. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years. Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511 [TBL] [Abstract][Full Text] [Related]
7. Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers. Unmack Larsen I; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A J Int Neuropsychol Soc; 2015 Mar; 21(3):193-202. PubMed ID: 25850430 [TBL] [Abstract][Full Text] [Related]
8. Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease. Dumas EM; Say MJ; Jones R; Labuschagne I; O'Regan AM; Hart EP; van den Bogaard SJ; Queller S; Justo D; Coleman A; Dar Santos RC; Dürr A; Leavitt BR; Tabrizi SJ; Roos RA; Stout JC J Huntingtons Dis; 2012; 1(1):97-106. PubMed ID: 25063192 [TBL] [Abstract][Full Text] [Related]
13. Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease. Corey-Bloom J; Gluhm S; Herndon A; Haque AS; Park S; Gilbert PE J Huntingtons Dis; 2016; 5(1):91-6. PubMed ID: 27003664 [TBL] [Abstract][Full Text] [Related]
14. Theory of mind can be impaired prior to motor onset in Huntington's disease. Eddy CM; Rickards HE Neuropsychology; 2015 Sep; 29(5):792-8. PubMed ID: 25664466 [TBL] [Abstract][Full Text] [Related]
15. Postural stability limits in manifest and premanifest Huntington's disease under different sensory conditions. Blanchet M; Prince F; Chouinard S; Messier J Neuroscience; 2014 Oct; 279():102-12. PubMed ID: 25168735 [TBL] [Abstract][Full Text] [Related]
16. Cognitive Fitness to Drive in Huntington's Disease: Assessing the Clinical Utility of DriveSafe DriveAware. Farrell HJ; Andrews SC; Ryan NP; Davis MC; Gordon S; Stout JC; Fisher F J Huntingtons Dis; 2019; 8(1):87-95. PubMed ID: 30776017 [TBL] [Abstract][Full Text] [Related]
17. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease. Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW Mov Disord; 2010 Oct; 25(13):2195-202. PubMed ID: 20645403 [TBL] [Abstract][Full Text] [Related]
18. Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington's Disease. Reyes A; Salomonczyk D; Teo WP; Medina LD; Bartlett D; Pirogovsky-Turk E; Zaenker P; Bloom JC; Simmons RW; Ziman M; Gilbert PE; Cruickshank T Sci Rep; 2018 Oct; 8(1):14615. PubMed ID: 30279429 [TBL] [Abstract][Full Text] [Related]
19. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR; Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354 [TBL] [Abstract][Full Text] [Related]
20. Speech biomarkers in Huntington's disease: A cross-sectional study in pre-symptomatic, prodromal and early manifest stages. Kouba T; Frank W; Tykalova T; Mühlbäck A; Klempíř J; Lindenberg KS; Landwehrmeyer GB; Rusz J Eur J Neurol; 2023 May; 30(5):1262-1271. PubMed ID: 36732902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]